Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Creemers

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Clinical and Translational Radiation Oncology|March 12, 2025
Prospective radiotherapy quality Assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II studyF Piqeur, B J P Hupkens, D M J Creemers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Annals of Surgical Oncology|September 27, 2007
A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancerL van de Schoot, E A P M Romme, M J van der Sangen, et al.
BMC Cancer|February 18, 2016
Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practiceL G E M Razenberg, Y R B M van Gestel, I H J T de Hingh, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2010
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the NetherlandsA E Dassen, V E P P Lemmens, L V van de Poll-Franse, et al.
Radiology. Imaging Cancer|June 27, 2025
Association of Pelvic Structure Involvement and Tumor Morphology at MRI with Prognosis Following Resection in Locally Recurrent Rectal CancerDavy M J Creemers, Henrik Iversen, Evi Banken, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 4, 2009
Identification of residual breast tumour localization after neo-adjuvant chemotherapy using a radioactive 125 Iodine seedY E A van Riet, A J G Maaskant, G J Creemers, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedureL J van Warmerdam, G J Creemers, S Rodenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumorsG J Creemers, C J Gerrits, J R Eckardt, et al.
Abdominal Radiology (New York)|November 29, 2023
The diagnostic accuracy of local staging in colon cancer based on computed tomography (CT): evaluating the role of extramural venous invasion and tumour depositsK van den Berg, S Wang, J M W E Willems, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Clinical and Translational Radiation Oncology|March 12, 2025
Prospective radiotherapy quality Assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II studyF Piqeur, B J P Hupkens, D M J Creemers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Annals of Surgical Oncology|September 27, 2007
A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancerL van de Schoot, E A P M Romme, M J van der Sangen, et al.
BMC Cancer|February 18, 2016
Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practiceL G E M Razenberg, Y R B M van Gestel, I H J T de Hingh, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2010
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the NetherlandsA E Dassen, V E P P Lemmens, L V van de Poll-Franse, et al.
Radiology. Imaging Cancer|June 27, 2025
Association of Pelvic Structure Involvement and Tumor Morphology at MRI with Prognosis Following Resection in Locally Recurrent Rectal CancerDavy M J Creemers, Henrik Iversen, Evi Banken, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 4, 2009
Identification of residual breast tumour localization after neo-adjuvant chemotherapy using a radioactive 125 Iodine seedY E A van Riet, A J G Maaskant, G J Creemers, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedureL J van Warmerdam, G J Creemers, S Rodenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumorsG J Creemers, C J Gerrits, J R Eckardt, et al.
Abdominal Radiology (New York)|November 29, 2023
The diagnostic accuracy of local staging in colon cancer based on computed tomography (CT): evaluating the role of extramural venous invasion and tumour depositsK van den Berg, S Wang, J M W E Willems, et al.
Pageof 10